Conmed: Reiterate Buy Rating As Earnings Are Expected To Grow Strongly (NYSE:CNMD)

Doctor, researcher or scientist browsing the internet on a tablet for information while working at a lab, science facility or hospital. Expert, medical professional or surgeon searching the internet

Sean Anthony Eddy

Investment action

I recommended a buy rating for Conmed (NYSE:CNMD) when I wrote about it the last time, as I was positive on the revised guidance, which reflected recovering share dynamics following the disruption early in 2023

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *